Literature DB >> 12204318

EEG mapping in seasonal affective disorder.

Nina V Volf1, Natalia R Passynkova.   

Abstract

Given that the nature of hemispheric dysfunction is different in heterogeneous disorders, in the present investigation EEG power mapping was applied to establish neurophysiological profiles that might potentially discriminate patients with seasonal affective disorder (SAD) among other affective disorders. The baseline resting EEG activity was recorded from 31 depressed SAD patients and 30 controls. Power in the delta, theta-1, theta-2, alpha, beta-1 and beta-2 frequency bands was extracted by Fourier transformation. Patients were found to have a lower delta (in central, parietal, occipital, temporal, posterior-temporal areas), theta-1 (in central and parietal), theta-2 (in anterior-frontal, parietal, occipital) and alpha activity (in anterior-frontal, midfrontal, central, parietal and occipital areas) than controls. SAD subjects showed, compared to controls, an asymmetrical distribution of delta, theta-1, theta-2 and alpha activity in parietal and temporal regions due to an increase of EEG power over the right electrode sites, and beta activity in the lateral frontal region due to an increase of beta power over the right electrode site. It is assumed that differential hemispheric contributions of EEG spectra may discriminate between the varieties of depression or different depressive states.

Entities:  

Mesh:

Year:  2002        PMID: 12204318     DOI: 10.1016/s0165-0327(01)00425-6

Source DB:  PubMed          Journal:  J Affect Disord        ISSN: 0165-0327            Impact factor:   4.839


  8 in total

1.  The oft-neglected role of parietal EEG asymmetry and risk for major depressive disorder.

Authors:  Jennifer L Stewart; David N Towers; James A Coan; John J B Allen
Journal:  Psychophysiology       Date:  2011-01       Impact factor: 4.016

2.  Association study of theta EEG asymmetry and brain-derived neurotrophic factor gene variants in childhood-onset mood disorder.

Authors:  Natalie L Bulgin; John S Strauss; Nicole A King; Sajid A Shaikh; Charles J George; Nathan A Fox; Cathy L Barr; Maria Kovacs; James L Kennedy
Journal:  Neuromolecular Med       Date:  2008-06-10       Impact factor: 3.843

3.  Low β2 Main Peak Frequency in the Electroencephalogram Signs Vulnerability to Depression.

Authors:  Damien Claverie; Chrystel Becker; Antoine Ghestem; Mathieu Coutan; Françoise Camus; Christophe Bernard; Jean-Jacques Benoliel; Frédéric Canini
Journal:  Front Neurosci       Date:  2016-11-02       Impact factor: 4.677

4.  Predictability of Seasonal Mood Fluctuations Based on Self-Report Questionnaires and EEG Biomarkers in a Non-clinical Sample.

Authors:  Yvonne Höller; Maeva Marlene Urbschat; Gísli Kort Kristófersson; Ragnar Pétur Ólafsson
Journal:  Front Psychiatry       Date:  2022-04-08       Impact factor: 5.435

5.  EEG-responses to mood induction interact with seasonality and age.

Authors:  Yvonne Höller; Sara Teresa Jónsdóttir; Anna Hjálmveig Hannesdóttir; Ragnar Pétur Ólafsson
Journal:  Front Psychiatry       Date:  2022-08-09       Impact factor: 5.435

6.  Yijinjing Qigong intervention shows strong evidence on clinical effectiveness and electroencephalography signal features for early poststroke depression: A randomized, controlled trial.

Authors:  Pingping Sun; Shuaipan Zhang; Linhong Jiang; Zhenzhen Ma; Chongjie Yao; Qingguang Zhu; Min Fang
Journal:  Front Aging Neurosci       Date:  2022-08-10       Impact factor: 5.702

7.  Resting posterior alpha power and adolescent major depressive disorder.

Authors:  Akina Umemoto; Lidia Y X Panier; Sally L Cole; Jürgen Kayser; Diego A Pizzagalli; Randy P Auerbach
Journal:  J Psychiatr Res       Date:  2021-07-08       Impact factor: 5.250

8.  Neurophysiologic Correlates of Post-stroke Mood and Emotional Control.

Authors:  Deniz Doruk; Marcel Simis; Marta Imamura; André R Brunoni; Leon Morales-Quezada; Renato Anghinah; Felipe Fregni; Linamara R Battistella
Journal:  Front Hum Neurosci       Date:  2016-08-30       Impact factor: 3.169

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.